Cargando…

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018

Influenza A(H3N2) viruses evade human immunity primarily by acquiring antigenic changes in the haemagglutinin (HA). HA receptor-binding features of contemporary A(H3N2) viruses hinder traditional antigenic characterization using haemagglutination inhibition and promote selection of HA mutants. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorquera, Patricia A., Mishin, Vasiliy P., Chesnokov, Anton, Nguyen, Ha T., Mann, Brian, Garten, Rebecca, Barnes, John, Hodges, Erin, De La Cruz, Juan, Xu, Xiyan, Katz, Jackie, Wentworth, David E., Gubareva, Larisa V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389938/ https://www.ncbi.nlm.nih.gov/pubmed/30804469 http://dx.doi.org/10.1038/s41598-019-39276-1

Ejemplares similares

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods
por: Patel, Mira C., et al.
Publicado: (2020)

Detection of oseltamivir‐resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test
por: Hodges, Erin N., et al.
Publicado: (2019)

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir
por: Patel, Mira C., et al.
Publicado: (2021)

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
por: Patel, Mira C., et al.
Publicado: (2022)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART
por: Gubareva, Larisa V, et al.
Publicado: (2017)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014)

Influenza Activity — United States, September 30–December 1, 2018
por: Budd, Alicia P., et al.
Publicado: (2018)

Update: Influenza Activity — United States, September 30, 2018–February 2, 2019
por: Blanton, Lenee, et al.
Publicado: (2019)

Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine
por: Garten, Rebecca, et al.
Publicado: (2018)

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
por: Okomo‐Adhiambo, Margaret, et al.
Publicado: (2013)

Update: Influenza Activity — United States, October 1, 2017–February 3, 2018
por: Budd, Alicia P., et al.
Publicado: (2018)

Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006–2008
por: Deyde, Varough, et al.
Publicado: (2009)

Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011
por: Lindstrom, Stephen, et al.
Publicado: (2012)

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022
por: Nguyen, Ha T., et al.
Publicado: (2023)

Update: Influenza Activity — United States and Worldwide, May 20–October 13, 2018
por: Chow, Eric J., et al.
Publicado: (2018)

Update: Influenza Activity — United States, October 2, 2016–February 4, 2017
por: Blanton, Lenee, et al.
Publicado: (2017)

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011
por: Nguyen, Ha T., et al.
Publicado: (2013)

Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine
por: Blanton, Lenee, et al.
Publicado: (2017)

Update: Influenza Activity in the United States During the 2018–19 Season and Composition of the 2019–20 Influenza Vaccine
por: Xu, Xiyan, et al.
Publicado: (2019)

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2010)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2015)

Update: Influenza Activity — United States and Worldwide, May 21–September 23, 2017
por: Blanton, Lenee, et al.
Publicado: (2017)

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Update: Influenza Activity — United States, September 28, 2014–February 21, 2015
por: D’Mello, Tiffany, et al.
Publicado: (2015)

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2014)

Update: Influenza Activity — United States, October 1–November 25, 2017
por: Dugan, Vivien G., et al.
Publicado: (2017)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

Influenza Activity — United States, 2014–15 Season and Composition of the 2015–16 Influenza Vaccine
por: Appiah, Grace D., et al.
Publicado: (2015)

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins
por: Marjuki, Henju, et al.
Publicado: (2016)

Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2013
por: Epperson, Scott, et al.
Publicado: (2013)

Molecular Epidemiology of Influenza A(H1N1)pdm09 Viruses from Pakistan in 2009–2010
por: Bashir Aamir, Uzma, et al.
Publicado: (2012)

745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States
por: Spencer, Sarah, et al.
Publicado: (2018)

Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine
por: Epperson, Scott, et al.
Publicado: (2019)

Update: Influenza Activity — United States, September 29–December 7, 2013
por: Brammer, Lynnette, et al.
Publicado: (2013)

Mapping of the US Domestic Influenza Virologic Surveillance Landscape
por: Jester, Barbara, et al.
Publicado: (2018)

R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses
por: Sleeman, Katrina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rvrq47irje60bfar0at0isimop